Literature DB >> 15780502

The role of viruses in cell fusion and its importance to evolution, invasion and metastasis of cancer clones.

George E Parris1.   

Abstract

The hypothesis described here is a logical extension of two areas of observation: First, it has been discovered that viruses (and perhaps other intracellular parasites) catalyze cell fusion as a means of cell-to-cell transmission. Effective cell-to-cell transmission appears to require: (i) induced expression of adhesion molecules on the cell surface; (ii) suppression of p53-dependent apoptosis; (iii) arrest of the cell cycle that would otherwise lead to cell death by "mitotic catastrophe". Suppression of apoptosis and cell death through "mitotic catastrophe" are important for formation of stable syncytia. Expression of Bcl-2 or a viral analogue of Bcl-2 (vBcl-2) is particularly useful to viruses because Bcl-2 both suppresses (p53-dependent) apoptosis and arrests the cell cycle through p27. Bcl-2 may also block any p53-independent cell death (e.g., mitotic catastrophe) that is initiated at the mitochondria. Second, it has been found that cell fusion plays a role in cancer clone evolution, invasion of normal cells in tissue adjacent to tumors and metastasis to remote normal tissues. Thus, it can be hypothesized that infection of cancer cells with viruses that spread by cell-to-cell transmission may coincidentally contribute to development of aggressive aneuploid clones and facilitate both invasion and metastasis of tumors. Regardless of the role of viruses, suppression of Bcl-2 may be an approach to preventing successful formation of syncytia and limiting the invasion and metastasis of tumors, thus, making surgical removal and radiation treatment more feasible.

Entities:  

Mesh:

Year:  2005        PMID: 15780502     DOI: 10.1016/j.mehy.2004.11.012

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  9 in total

Review 1.  Cell fusion as a hidden force in tumor progression.

Authors:  Xin Lu; Yibin Kang
Journal:  Cancer Res       Date:  2009-11-03       Impact factor: 12.701

Review 2.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

Review 3.  Regulation of the metastasis suppressor Nm23-H1 by tumor viruses.

Authors:  Shuvomoy Banerjee; Hem Chandra Jha; Erle S Robertson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-10       Impact factor: 3.000

4.  The problem of colliding networks and its relation to cell fusion and cancer.

Authors:  Alexei A Koulakov; Yuri Lazebnik
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

5.  Proteomics informed by transcriptomics for characterising differential cellular susceptibility to Nelson Bay orthoreovirus infection.

Authors:  Lawrence Mok; James W Wynne; Mary Tachedjian; Brian Shiell; Kris Ford; David A Matthews; Antony Bacic; Wojtek P Michalski
Journal:  BMC Genomics       Date:  2017-08-14       Impact factor: 3.969

Review 6.  The natural adaptive evolution of cancer: The metastatic ability of cancer cells.

Authors:  Gheorghe-Emilian Olteanu; Ioana-Maria Mihai; Florina Bojin; Oana Gavriliuc; Virgil Paunescu
Journal:  Bosn J Basic Med Sci       Date:  2020-08-03       Impact factor: 3.363

7.  Cell fusion as a link between the SARS-CoV-2 spike protein, COVID-19 complications, and vaccine side effects.

Authors:  Yuri Lazebnik
Journal:  Oncotarget       Date:  2021-12-07

8.  Fusion of CCL21 non-migratory active breast epithelial and breast cancer cells give rise to CCL21 migratory active tumor hybrid cell lines.

Authors:  Benjamin Berndt; Sonja Haverkampf; Georg Reith; Silvia Keil; Bernd Niggemann; Kurt S Zänker; Thomas Dittmar
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

9.  Human endogenous retroviral K element encodes fusogenic activity in melanoma cells.

Authors:  Gengming Huang; Zhongwu Li; Xiaohua Wan; Yue Wang; Jianli Dong
Journal:  J Carcinog       Date:  2013-03-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.